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Abstract.  It has recently become apparent that colla- 
gen fibrils may be composed of more than one kind of 
macromolecule. To explore this possibility, we devel- 
oped a procedure to purify fibril fragments from 17-d 
embryonic chicken sternal cartilage.  The fibril popula- 
tion obtained shows, after negative staining, a unifor- 
mity in the banding pattern and diameter similar to the 
fibrils in situ. Pepsin digestion of this fibril prepara- 
tion releases collagen types II, IX, and XI in the 
proportion of 8:1:1. Rotary shadowing of the fibrils re- 
veals a d-periodic distribution of 35-40-nm long 
projections, each capped with a globular domain, 
which resemble in form and dimensions the amino- 
terminal globular and collagenous domains, NC4 and 
COL3, of type IX collagen. The monoclonal antibody 
(4D6)  specific for an epitope close to the amino termi- 
nal of the COL3 domain of type IX collagen bound to 
these projections, thus confirming their identity. Type 
IX collagen is therefore distributed in a  regular d-peri- 
odic arrangement along cartilage fibrils, with the 
chondroitin sulfate chain of type IX collagen in inti- 
mate contact with the fibril. 
major question in cell biology is how individual mac- 
romolecules combine to form the often large and 
complex supramolecular structures of  the extracellu- 
lar matrix. Approaches to this problem include the direct mi- 
croscopic visualization of tissue sections aided by chemical 
stains and immunological tools, reconstitution and binding 
studies with purified components in solution followed by 
analysis of the resulting products, and, where possible, di- 
rect x-ray analysis of highly ordered arrays in situ. 
This strategy is particularly well exemplified by the many 
detailed studies of collagen fibrils and fibrillogenesis. This 
work has resulted in an understanding of the interactions that 
govern lateral association of fibrillar collagens (for recent 
reviews see references 3,  7,  and  19). The quarter stagger 
model that arose from these studies has been considerably 
refined since its introduction, but still remains as the corner- 
stone of current models as it explains how fibrils formed in 
vitro from purified collagen molecules give rise to the char- 
acteristic staining patterns observed in the electron micro- 
scope. Although the fibril staining patterns produced in vitro 
match those seen in vivo, the diameter regulation of collagen 
fibrils in vivo and their complexity, including association 
with other components, especially proteoglycans, are fea- 
tures  not reproduced by mixing solutions of collagens in 
vitro. In summary, two critical questions remain: how is the 
construction of fibrils regulated in vivo and what role might 
other molecules play in these processes? 
This problem is particularly well illustrated in cartilage. 
The morphology of fibrils reconstituted from purified type 
II collagen in solution is vastly different from that of cartilage 
fibrils  in  situ.  Large tactoidal aggregates with d-periodic 
staining patterns are formed under appropriate reconstitution 
conditions (21). In contrast,  fibrils from chicken embryo 
sternal cartilage (for example) are long cylindrical structures 
with a uniform diameter of '~20 nm. This discrepancy has 
stimulated the search for additional components regulating 
fibril assembly. Although a number of proteins and proteo- 
glycans have been shown to interact with type II collagen in 
vitro (6, 25, 33) there is to date little proof that these are the 
regulatory components in vivo. On the other hand, that pro- 
teoglycans and collagen fibrils are intimately associated can 
be seen from ultrastructural studies of the cartilage matrix 
(13). In addition, it has been proposed that proteoglycans are 
distributed in a periodic manner along type I collagen fibrils 
in various tissues, including annulus fibrosus (T/),  rat tail 
tendon, and cornea (26). 
Cartilage also contains collagen types IX and XI, each of 
which must be an integral part of the fibrillar network, but 
whose roles and exact ultrastructural distributions are un- 
known. It is quite conceivable that collagen types II, IX, and 
XI interact to form cartilage fibrils. Certainly, type IX colla- 
gen  has  been  detected  on  fine  nonstriated  fibrils  in  the 
pericellular matrix of fetal calf cartilage (10) and has been 
reported localized to the intersections of type II collagen 
fibrils in chicken embryo sternum (24).  Evidence has also 
been presented for the existence of mixed fibrils of collagen 
types I and HI (16) and collagen types I and V (2, 22), with 
type V collagen reportedly able to regulate the diameter of 
type I collagen fibrils formed in vitro (1). 
Here we have isolated collagenous fibrils from cartilage 
and have analyzed them by a combination of protein-chemi- 
cal, immunological, and ultramicroscopical methods. This 
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the uniformity  in diameter  and  in staining pattern.  Bar,  300  nm. 
work demonstrates that  a  preparation  of fibril  fragments 
from cartilage contains collagen types II, IX, and XI and that 
type IX  collagen is distributed d-periodically along these 
fibrils. The results illustrate the complexity of the collagen 
fibril in situ and raise a number of questions as to how its 
synthesis might be controlled. 
Materials and Methods 
Extraction, Isolation, and Purification of the Fibrils 
Sternal cartilages were dissected from 17-d-old chicken embryos and the ad- 
herent  perichondria  carefully  removed.  All  subsequent  steps  were  per- 
formed at 4~  The cleaned cartilages were homogenized with a Polytron, 
followed by extraction for 20 h  in a  1M NaCI solution buffered to pH 7.4 
with 0.05  M  Tris-HCl and containing a mixture of proteinase inhibitors (1 
mM phenylmethylsulfonyl fluoride, 0.1  M  6-aminohexanoic acid,  10 mM 
N-ethylmaleimide, and 10 mM disodium EDTA). The resulting suspension 
was centrifuged at 27,000 g  for 30 rain and the clear supernatant recen- 
trifuged at 115,000 g  for 2 h. The final pellet obtained was resuspended by 
vigorous vortexing in either the 1 M NaCI buffer described above or in an 
8  M  urea solution containing 150 mM NaC1 and buffered to pH 7.4 with 
0.05 M Tris-HCt and then recentrifuged at 115,000 g for 2 h. This procedure 
was repeated twice to obtain the cartilage fibril fragments free of single col- 
lagen molecules.  For enzyme digestions, the final fibril pellet was resus- 
pended in an isotonic Tris buffer, pH  8.0. 
Enzymatic Digestions 
1~'ypsin. To the fibril suspension in a 0.05 M Tris/HC1 buffer, pH 8.0, con- 
taining 0.15 M NaCI, trypsin was added to give a final concentration of 0.1 
mg/ml and the digest incubated at room temperature with continuous stir- 
ring for 4  h. Afterwards the digest was centrifuged at 115,000 g  for 2  h at 
4~  The pellet contains the trypsinized fibrils. 
Pepsin. The fibril preparation, either direcdy or after trypsinization, was 
resuspended in a buffer ot'0.5 M acetic acid, 0.2 M NaCl titrated to pH 2.0 
with HCI, recentrifuged at 115,000 g  for 2 h at 4~  and resuspended in the 
above buffer. Pepsin was added to give a final concentration of 0.5 mg/ml 
and the digestion mixture incubated with continuous stirring at 4oC over- 
night. The digest was neutralized with crystals of "his and centrifuged at 
115,000 g for 2 h at 4~  The supernatant contained the pepsin-resistant do- 
mains of the fibril collagens. 
SDS-PAGE 
Gradient gels of 4-10% wt/vot potyacrylamide were prepared and run using 
standard methods (20). 
Scanning of  the Gels 
The  Coomassie  Blue-stained  gels  were  scanned  at  ~.  =  560  nm on a 
Shirnadzu Chromatogram Densitometer CD  50 (Desaga GmhH,  Heidel- 
berg, Federal Republic of Germany).  In the collagen concentration range 
used, staining is a linear function of the amount of collagen applied to the 
gel. Estimations were based on scanning the al(II) band for type II collagen, 
the  high  molecular  weight  (HMW)  band  for type  IX  collagen,  and  the 
al(XI) band for type XI collagen, with appropriate corrections to obtain the 
respective collagen amount. The HMW bands of I~ and "/mobility, cross- 
linked collagen chains, were excluded from the estimations. 
Amino Acid Analysis 
Amino acid analysis of gas phase hydrolyzed samples was performed ac- 
cording  to  the  dimethylaminoazobenzene  sulfonyl  chloride  (DABS-C1) 
method (17). Separation of the derivatized amino acids was by high perfor- 
mance liquid chromatography  using a  Nucteosil 5-100-C18  reverse phase 
column (Macherey and Nagel,  Oensingen, Switzerland). 
Electron Microscopy 
Negatively Stained Specimens. Aliquots of the purified cartilage fibril sus- 
pension  were  spotted  onto  sheets of Parafilm.  Carbon-coated  400-mesh 
copper grids were floated on the drops for 1 rain to absorb the fibrils, then 
Figure  2.  Pepsin  solubilization 
of  cartilage  fibrils.  Fibrils  af- 
ter  repeated  centrifugation  and 
washing  in  8  M  urea  at  4~ 
were  incubated  in SDS-sample 
buffer and subjected to electro- 
phoresis  in  4-10%  polyacryl- 
amide gels (lane 1).  Treatment 
of the washed fibril preparation 
with trypsin produced the result 
shown in lane 2. Digestion of ei- 
ther fibril preparation with pep- 
sin resulted in the pattern shown 
in  lane  3.  The  electrophoretic 
mobilities of the al(II)  and  ttl, 
a2,  0t3(XI)  collagen  chains  as 
well  as  the  HMW  and  LMW 
fragments  of type  IX  collagen 
are indicated. 
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with the absorbed fibrils were then floated  on a drop of a 2% uranyl  acetate 
solution for 5 rain, removed, drained of excess solution, and air-dried. 
Rotary Shadowed Specimens. Purified fibrils were dialyzed  against sev- 
eral changes of 0.2 M ammonium  bicarbonate. Aliquots, either directly or 
after incubation with mAbs  4I)6 or 2C2 for 1-2 h at 25"C, were mixed 1:1 
vol/vol with glycerol and immediately sprayed onto freshly cleaved mica. 
After drying under a vacuum of approximately 10  -7 torr for 3-5 h, the 
fibrils were shadowed at 9  ~ with platinum/carbon and then at 90  ~ with a 
supporting film of carbon. This film was then floated  onto water and picked 
up on 400-mesh  copper grids. Transmission  electron micrographs  were  pre- 
pared. The contour  lengths  of structures in the micrographs  were measured 
using a graphics tablet (Kontron Elektronik GmbH, Ziirich). 
Monoclonal Antibodies.  The 2C2 and 4D6 mAbs were prepared and 
characterized as previously described (14). 
Results 
The  low  speed  centrifugation  of  a  1-M  NaC1  extract  of 
chicken  embryo  sterna  effectively  removed  tissue  debris. 
Centrifugation  of the clear supernatant  at high speed pro- 
duced a noticeable pellet, which by repeated washing in 8 M 
urea and centrifugation was freed from individual collagen 
molecules as judged by SDS-PAGE (see Fig. 2, lane 1 ). The 
final pellet was then resuspended in an isotonic Tris buffer, 
pH 8.0, and examined in the electron microscope after nega- 
tive staining  (Fig.  1).  Fragments of fibrils,  with a  periodic 
staining pattern of 65 nm and a highly uniform diameter of 
16.7, SD 1.1 nm (n =  62) were observed. Very rarely, thicker 
fibrils  were also present.  Crude fibril  preparations,  exam- 
ined before extensive washing were similar (not shown). The 
uniform appearance and dimensions of  the thin fibrils closely 
resembled the in situ stained fibrils of 17-d embryonic chicken 
sternal cartilage (24). 
The composition of these fibrils  was examined on SDS- 
PAGE after proteolytic digestion with pepsin.  Fibrils  were 
either treated  with pepsin directly or after incubation with 
trypsin to remove contaminating proteins and proteoglycans 
that might complicate the analysis by scanning of the stained 
gels. Under our conditions, trypsin treatment neither affects 
triple helical domains and nor does it change the appearance 
of the negatively stained  specimens  in the electron micro- 
scope. The washed (Fig. 2, lane 1 ) and also the trypsinized 
fibrils (lane 2) show a Coomassie Blue-stained material that 
does  not enter  the  stacking gel,  as  would be  expected  for 
covalently cross-linked collagenous fibrils. Pepsin treatment 
caused this material to disappear with the concurrent appear- 
ance of bands with mobilities  corresponding to the peptic 
fragments of collagens type II, type IX (HMW and LMW), 
and type XI (Fig.  2,  lane 3).  Scanning of the gel followed 
by a correction for the differing molecular weights of the col- 
lagens types II, IX, and XI gave a molar ratio of 8:1:1, respec- 
tively. The fibrils resist solubilization not only in 1 M  NaCl 
or 8 M urea but also in 0.5 M acetic acid, the latter normally 
used to dissolve collagens,  indicating the presence of cova- 
lent  cross-links  stabilizing  the  fibrils.  Indeed,  to  release 
>90% of the collagens from the fibrils, relatively high amounts 
of pepsin were necessary (see Fig. 2, lane 3). The efficiency 
of pepsinization was confirmed by amino acid analysis, which 
Figure 3. Rotary-shadowed cartilage fibril. The fibril in this electron 
micrograph appears to be sheathed in type IX collagen (inset). The 
globular amino-terminal domain (1) and a short noncollagenous 
domain (NC3),  which gives rise  to a  prominent kink (2)  in the 
otherwise relatively rigid collagenous portion, are notable features 
also visible in the molecules on the fibril surface. Where partial dis- 
sociation of the fibril has occurred (*), the individual  molecules of 
type IX collagen appear to be aligned along the fibril. Bar, 100 nm. 
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Figure 4.  Model showing the major features of type IX collagen. 
Three collagenous regions (COL1-3) and four noncollagenous  do- 
mains (NC1-4) combine to form a molecule (28) that measures 
,~190 nm in rotary-shadowed  micrographs (15). The glycosamino- 
glycan chain is attached to the r  polypeptide (11, 18) at the 
NC3 domain (12, 15, 23). The sites of the epitopes for the 4D6 (zx) 
and 2C2 (A) mAbs are indicated. 
revealed that 95 % of the fibril hydroxyproline was solubi- 
lized by this procedure. 
The fibrils were also examined in the electron microscope 
after rotary shadowing with platinum/carbon (Fig. 3). Espe- 
cially noteworthy in these micrographs were the regularly 
spaced projections, each capped with what appears to be a 
globular domain. The dimensions and appearance of these 
projections  closely resemble  the amino-terminal globular 
(NC4) and collagenous (COL3) domains of type IX collagen 
(see Fig. 3, inset, and Fig. 4). Where partial dissociation of 
the fibril has occurred, the individual molecule appears to 
be aligned along the fibril. 
To test whether these projections are indeed the amino ter- 
minal domains of  type IX collagen, we used two monoclonal 
antibodies, 2C2 and 4D6, specific for type IX collagen (14). 
Both these antibodies were raised against the collagenous do- 
mains COL3 and COL2 (together comprising HMW) gener- 
ated through pepsin cleavage of type IX collagen. The mAb 
2C2 bound close to the carboxyl-terminal of  COL2 and mAb 
4D6 bound to an epitope near the amino-terminal end of 
COL3 (Fig. 4).  Because of the proximity of the epitope of 
4D6 to the amino-terminal globular domain (NC4) of type 
IX collagen, the antibody could be partly obscured by the 
amino-terminal domain. For this reason, a control panel of 
purified type IX collagen molecules, rotary shadowed after 
incubation with the 4D6 mAb, is presented for comparison 
in Fig. 5. 
Incubation of the fibrils with the 4D6 mAb followed by ro- 
tary shadowing led to images such as those shown in Fig. 6. 
Here the 4D6 mAbs can be clearly seen binding close to the 
globular domains of the projections. The frequency of bind- 
ing was ",~25  %, consistent with the frequency observed with 
the 4D6 mAb on purified type IX collagen. This somewhat 
low frequency most likely reflects a partial steric hindrance 
by the amino-terminal domain of  antibody binding to the epi- 
tope. Conversely, after incubation of the fibrils with the 2C2 
mAb, only irregular binding could be observed, although the 
same antibody bound at a high frequency to individual type 
IX collagen molecules. Thus it would appear that the 2C2 
mAb epitope is not readily available in the fibril, but, as ex- 
pected,  in  regions of partial  fibril  dissociation increased 
binding of the 2C2 mAb was detected (not shown). 
In an attempt to quantitate the relative binding of mAbs 
2C2 and 4D6 to the fibrils, we measured in micrographs of 
rotary-shadowed specimens the orthogonal distance, relative 
to the fibril axis, of all antibodies from the outside edge of 
the fibrils.  These  results are presented in the histograms 
shown in Fig. 7. Whereas the 2C2 mAbs are randomly dis- 
tributed, the 4D6 mAbs show a clear peak at 30-40 nm from 
the fibril. This corresponds to the length of the projections, 
measured from the middle of the amino-terminal globular 
domain to the edge of the fibril of 35-40 nm (Fig. 8). 
The distribution of type IX collagen along the fibrils was 
analyzed (Fig. 9). Histograms were prepared of the distance 
between adjacent and clearly distinct projections of type IX 
collagen. Poorly resolved projections were not included in 
the data, a factor that would naturally bias the sample ana- 
lyzed towards  type IX collagen molecules projecting later- 
ally from the fibril edge. This distribution centers on a broad 
peak at •65  nm, with smaller broad peaks at 130 and 195 
nm. This periodicity corresponds to the "d-stagger" distance 
in fibrils of type II collagen of 67 nm (8, 21). Two additional 
observations are also noteworthy. Two type IX collagen pro- 
jections frequently appeared to emanate from either the same 
point on one side of the collagen fibril (see, e.g., Fig. 5) or 
directly opposite on the other side of the fibril. On the other 
hand, projections from intermediate points within the d-pe- 
riod were relatively infrequent. 
Discussion 
The direct analysis presented here of isolated collagen fibril 
fragments from cartilage gives new insights into fibril ar- 
chitecture and structure. The uniformity in dimensions and 
Figure 5. Rotary-shadowed  micrographs of type IX collagen mole- 
cules after incubation with the 4D6 mAb. The 4D6 mAb ranges in 
appearance from triangular to globular and can be seen binding 
close to the amino-terminal  globular domain, which is occasionally 
obscured. Bar, I00 nm. 
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mAb 4D6 before rotary shadowing.  The 
binding of the 4D6 mAb (}-) immedi- 
ately adjacent to the globular domain of 
the projections (.--}) can be clearly seen. 
The bivalent binding of two projections 
by the one mAb is also evident, indica- 
tive of a close spatial juxtaposition of the 
type IX collagen molecules in the fibril. 
Bar,  100 nm. 
appearance of 17-d chicken  embryo sternal  cartilage fibrils 
(24)  facilitated  both  the  ultrastructural  analyses  and  the 
purification of fibril fragments. Biochemical evidence estab- 
lishing the presence of collagen types II, IX, and XI in the 
isolated fibril population  is forthcoming from peptic diges- 
tion  of the  fibrils.  Quantification  of the  Coomassie  Blue- 
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Figure 7. Histogram showing the distribution of mAbs 4D6 and 2C2 
relative to the fibrils in rotary-shadowed electron micrographs. The 
fibrils were incubated with either the 4D6 or the 2C2 antibodies 
and  the  shortest  distance  from the  fibril edge to each  antibody 
measured. 
stained  peptic fragments  showed,  as expected,  that type II 
collagen  makes  up  some  80%  of the  total  collagen  in  the 
fibrils. Collagen types IX and XI contributed the remainder 
in approximately equal amounts. This does not provide proof 
that all three collagens coexist in the one fibril. This can only 
be established from ultrastructural  analyses, shown here for 
type IX collagen and in a subsequent manuscript, to be pub- 
lished  elsewhere,  for type XI collagen. 
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Figure & Histogram of the contour lengths of projections measured 
from departure point at the fibril side to the middle of the globular 
domain. The corresponding distance from the hinge (NC3) to the 
middle of the amino-terminal globular domain of type IX collagen 
is ,~40 nm (15). 
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Figure 9. Histogram of the longitudinal  distribution of type IX col- 
lagen on the fibril surface. The contour distances between dearly 
distinct projections along the same side of fibrils were measured 
and are plotted above. The major peak corresponds to a d-period 
of 65 nm (~), with minor peaks arising at approximately 2d- and 
3d-periods. 
The new approach developed here of rotary shadowing on 
isolated fibril fragments has enabled us to directly establish 
the  ultrastructural  distribution of type IX  collagen.  The 
identification of collagen type IX in the fibril is based on ap- 
pearance, dimensions, and immunological identity utilizing 
a  specific monoclonal antibody. The projections from the 
cartilage fibrils with their relatively rigid rodlike section 
capped by a terminal globular domain are closely compara- 
ble in form and dimensions with the amino terminal collage- 
nous (COL3) and noncollagenous (NC4) domains of type IX 
collagen. This assignment is confirmed immunologically by 
the specific binding of the mAb 4D6, which binds both at the 
amino-terminal end of the COL3 domain of type IX collagen 
and at the corresponding position in the fibril projections. 
The evidence that the long arm of type IX collagen, includ- 
ing collagenous domains  1 and 2  (COL1  and COL2) lies 
along the surface rather than being buried deeply within the 
fibril is as yet only tentative, being based on observations of 
the partially dissociated fibril. The poor binding of the 2C2 
mAb to the fibril indicates, however, that, at least, access to 
this epitope on the long arm is in some way hindered. 
Type IX collagen represents ~10% of the fibrillar colla- 
gen, a proportion consistent with a distribution restricted to 
the surface of the collagen fibril. Indeed, it is difficult to en- 
visage how type IX collagen with its interrupted triple helical 
structure and glycosaminoglycan chain (4, 28, 31) attached 
to the NC3 domain (12, 15, 23) could fit within the relatively 
tight packing of a  fibril core.  Possibly the best reference 
model for the packing within these fibrils to date is that pro- 
posed from the x-ray diffraction data for 17-nm collagenous 
fibrils from lamprey notochord sheath (3). These fibrils are 
composed of collagen types II and XI and have similar di- 
mensions to the chicken embryo cartilage fibrils isolated 
here. Based on these data one would expect *80 collagen 
molecules per fibril cross-section. If only eight of these are 
type IX collagen, then there can clearly not be a continuous 
sheath of type IX around the fibril surface. Therefore either 
type II and/or type XI collagen must also be exposed on the 
fibril surface. 
The distribution of type IX collagen in the longitudinal 
axis of the isolated fibrils with a spacing of one d-period is 
clearly shown in the rotary-shadowed micrographs. That this 
periodicity is so readily observed is most likely also a func- 
tion of a  discontinuous sheath of type IX collagen on the 
fibril surface. The preparative procedure for rotary shadow- 
ing would certainly also play a role. Projections from the side 
of the fibrils would be encouraged to spread out on contact 
with the mica surface, whereas those lying along the top of 
the fibrils would tend to collapse onto the fibril and be lost 
to view. Because this methodology visualizes surface relief 
only poorly, the relative position of type IX collagen with re- 
spect to other collagens can not be determined directly. How- 
ever,  if the previous localization of glycosaminoglycans to 
the d-band of type I collagen fibrils in tissue sections is mir- 
rored in cartilage by the chondroitin sulphate chains of type 
IX collagen, then this would imply that the NC3 or "hinge" 
region is positioned next to this gap region in the fibril and 
in juxtaposition to the amino-telopeptide of type II collagen. 
Firm evidence in support of this has recently been obtained 
(9; van der Rest, M., and R. Mayne, manuscript submitted 
for publication). A tryptic peptide was isolated from a peptic 
digest of chicken cartilage and shown on the basis of its 
fluorescence spectrum to contain a trivalent hydroxypyridi- 
nium cross-link. Based on its amino acid double sequence, 
one peptide could be shown to be derived from the amino- 
terminal end of the COL2 fragment of the et2(IX) collagen 
chain, i.e., near the hinge, the other from the amino-telo- 
peptide region of type II collagen. The corresponding pep- 
tide has also been isolated from bovine cartilage and se- 
quenced (9)  along with an additional peptide containing a 
trivalent cross-link between type IX and type II collagens. 
Although the exact organization of type IX collagen within 
the cartilage fibrils cannot yet be ascertained, the surface 
properties brought about by the projections of type IX colla- 
gen begin to emerge. The periodically arranged chondroitin 
sulfate chains  may either  extend away  from the  fibril  to 
potentially interact with other component(s) of the cartilage 
matrix or may primarily interact with collagens or other 
molecules in the fibrils themselves. Another aspect to be 
considered is the orientation of the amino-terminal domain 
of type IX collagen in the fibrils. No function has yet been 
ascribed to this globular portion of type IX collagen, al- 
though it is reported to have a pI of  9.8 (30), making it clearly 
a candidate to interact with the polyanionic proteoglycans 
abundant in cartilage.  In this context, the function of the 
COL3 domain may be to provide a spacer arm to project the 
NC4 domain away from the fibril to facilitate interactions 
with the proteoglycans. The COL1  and COL2 domains of 
type IX collagen (see Fig. 4) are presumably necessary for 
the interactions with collagen type II (and possibly type XI) 
in the fibril. The contact with the aggregating proteoglycans 
in the interfibrillar space as well as anchorage to cells may 
additionally be mediated by one or several  of the cartilage 
glycoproteins described recently (5, 25, 29, 32, 33), some of 
which appear able to bind to collagen. 
The concept of the collagen fibers as not only structural 
elements but as vehicles for the presentation in the extracel- 
lular milieu of varied macromolecular signals is attractive. 
The direct use of isolated fibrils in functional assays may pro- 
vide insights into extracellular matrix interactions not possi- 
ble with individual components. How the cell regulates the 
synthesis of these fibrils, in particular at the level of the gone 
with the coordinate regulation of six gene products for the 
three collagens necessary, is a challenging question. 
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